Since overexpression of both Rab-A9 and NPC1 proteins have been shown to reduce the symptoms of the NPC disease45,46, we hypothesized that the common predicted activator (Thiabendazole) may inhibit the progression of the NPC disease. Here, NPC1 is linked to nasopharyngeal carcinoma.